ICMR partners with BBIL for developing indigenous COVID-19 vaccine
May 09, 2020
New Delhi, May 9 [India], May 9 : The Indian Council of Medical Research (ICMR) on Saturday announced that it has partnered with the Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for COVID-19 using the virus strain isolated at the National Institute of Virology (NIV), Pune.
"The ICMR and BBIL have partnered to develop a fully indigenous vaccine for COVID-19 using the virus strain isolated at the ICMR's NIV, Pune," a ICMR statement said.
The strain has been successfully transferred from NIV to BBIL and work on vaccine development has been initiated between the two partners.
While the ICMR-NIV will provide continuous support to BBIL for vaccine development, the ICMR and BBIL will seek fast-track approvals to expedite vaccine development, subsequent animal studies and clinical evaluation of the candidate vaccine.
